Corcept Therapeutics

+$0.16 (+0.78%) Today
$0.00 (0.00%) As of 9:14 PM UTC after-hours

Why Robinhood?

You can buy or sell CORT and other stocks, options, and ETFs commission-free!

About CORT

Corcept Therapeutics Incorporated Common Stock, also called Corcept Therapeutics, is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol.

CEO
Joseph K. Belanoff
Employees
236
Headquarters
Menlo Park, California
Founded
1998

CORT Key Statistics

Market Cap
2.54B
Price-Earnings Ratio
25.32
Dividend Yield
—
Average Volume
673.61K
High Today
$20.97
Low Today
$20.23
Open Price
$20.23
Volume
1.09M
52 Week High
$31.18
52 Week Low
$12.20

CORT Earnings

$0.19
$0.24
$0.29
$0.34
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
$0.21 per share
Actual
$0.20 per share
Replay Earnings Call

You May Also Like

BOAC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure